Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK.
Pediatr Pulmonol. 2013 Jul;48(7):683-92. doi: 10.1002/ppul.22766. Epub 2013 Feb 8.
In 1995 the Tucson Children's Respiratory Study (TCRS) identified clinically distinct phenotypes amongst early wheezers; the Avon Longitudinal Study of Parents And Children (ALSPAC) has recently re-examined these.
To validate statistically derived ALSPAC phenotypes in the Southampton Women's Survey (SWS) using infant and 6-year lung function, and allergic sensitization at 1, 3, and 6 years, comparing these with TCRS phenotypes.
Complete 6-year follow-up data were available for 926 children, selected from 1,973 infants born to 12,579 women characterized pre-conception. Ninety-five children had V'maxFRC and FEV0.4 measured age 5-14 weeks using rapid compression/raised volume techniques. At 6 years we performed spirometry (n = 791), fractional exhaled nitric oxide (FeNO, n = 589) and methacholine challenge (n = 234). Skin prick testing was performed at 12m, 3 and 6 years (n = 1,494, 1,255, 699, respectively). Using wheeze status questionnaire data at 6m, 12m, 2, 3 and 6 years we classified children into TCRS (never, transient early, persistent, late-onset) and ALSPAC based groups (never, early, transient, intermediate-onset, late-onset, persistent).
Amongst ALSPAC groups, persistent and late-onset wheeze were associated with atopy at 3 and 6 years, whilst intermediate-onset wheeze showed earlier atopic association at 1 year; all three were associated with FeNO at 6 years. Persistent wheezers had lower infant (V'maxFRC P < 0.05) and 6-year lung function (FEV1, FEV1/FVC, and FEF(25-75), P < 0.05), whilst late and intermediate-onset wheezers showed no lung function deficits. Transient wheezers were non-atopic but showed persistent lung function deficits (V'maxFRC in infancy, FEV1 and FEF(25-75) at 6 years, all P < 0.05). Those who wheezed only in the first year (early phenotype) showed no lung function deficits. No associations were seen with 6 years bronchial hyper-responsiveness or infancy FEV0.4.
SWS cohort data validates the statistically derived ALSPAC six-class model. In particular, lung function and atopy successfully differentiate persistent, late-onset and intermediate-onset wheeze, whilst the Tucson "transient early" wheeze phenotype can be sub-classified into groups that reflect early lung function. Since the 4-class model fails to adequately differentiate phenotypes based on lung function and atopy, we propose that strong consideration be given to using the 6-class paradigm for longitudinal outcome work in wheezing with onset in early life.
1995 年,图森儿童呼吸研究(TCRS)在早期喘息的儿童中确定了临床特征明显的表型;阿冯纵向研究父母和儿童(ALSPAC)最近重新研究了这些表型。
使用婴儿和 6 岁时的肺功能以及 1 岁、3 岁和 6 岁时的过敏致敏情况,统计验证南安普顿妇女调查(SWS)中衍生的 ALSPAC 表型,并将这些表型与 TCRS 表型进行比较。
从 12579 名女性中选择了 1973 名 1 岁的婴儿,对这些女性进行了孕前特征描述,为其中 926 名儿童提供了完整的 6 年随访数据。95 名儿童在 5-14 周时使用快速压缩/升高体积技术测量了 V'maxFRC 和 FEV0.4。在 6 岁时,我们进行了肺活量测定(n=791)、呼出气一氧化氮分数(FeNO,n=589)和乙酰甲胆碱激发试验(n=234)。在 12 个月、3 个月和 6 岁时进行了皮肤点刺试验(n=1494、1255、699)。使用 6 个月、12 个月、2、3 和 6 岁时的喘息状态问卷数据,我们将儿童分为 TCRS(从未、早期一过性、持续性、迟发性)和 ALSPAC 基于组(从未、早期、一过性、中间发作、迟发性、持续性)。
在 ALSPAC 组中,持续性和迟发性喘息与 3 岁和 6 岁时的特应性有关,而中间发作性喘息在 1 岁时就表现出更早的特应性关联;所有这三种情况在 6 岁时均与 FeNO 有关。持续性喘息者婴儿期(V'maxFRC,P<0.05)和 6 岁时的肺功能(FEV1、FEV1/FVC 和 FEF(25-75),P<0.05)较低,而迟发性和中间发作性喘息者则没有肺功能缺陷。一过性喘息者非特应性,但存在持续的肺功能缺陷(婴儿期的 V'maxFRC,6 岁时的 FEV1 和 FEF(25-75),均 P<0.05)。那些仅在第一年喘息的人(早期表型)没有肺功能缺陷。6 岁时的支气管高反应性或婴儿期 FEV0.4 与任何表型均无关联。
SWS 队列数据验证了统计衍生的 ALSPAC 六类模型。特别是,肺功能和特应性成功地区分了持续性、迟发性和中间发作性喘息,而图森“早期一过性”喘息表型可以进一步分为反映早期肺功能的组别。由于 4 类模型不能充分区分基于肺功能和特应性的表型,我们建议在早期生命喘息的纵向结局研究中,强烈考虑使用 6 类范式。